Page last updated: 2024-10-30

ketotifen and Granulocytic Leukemia

ketotifen has been researched along with Granulocytic Leukemia in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Research Excerpts

ExcerptRelevanceReference
"Primary acute myelogenous leukemia blast cell viability was reduced 4."1.31Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. ( Berger, SA; Minden, M; Soboloff, J; Zhang, Y, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soboloff, J1
Zhang, Y1
Minden, M1
Berger, SA1

Other Studies

1 other study available for ketotifen and Granulocytic Leukemia

ArticleYear
Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging.
    Experimental hematology, 2002, Volume: 30, Issue:10

    Topics: Animals; Bone Marrow Cells; Bone Marrow Purging; Calcium; Calcium Channel Blockers; Cell Death; Econ

2002
chemdatabank.com